Dr. de Jong treats children with all types of cancer and blood diseases. She is the Director of Pediatric Hematology and has specialized expertise in bone marrow failure, leukemia, autoimmune blood diseases (such as autoimmune hemolytic anemia, autoimmune neutropenia, immune thrombocytopenia purpura and Evans syndrome), hemoglobinopathies (such as thalassemia and sickle cell disease), and bleeding and clotting disorders.
Her research focuses on hematopoietic stem cells and genetic risks for hematologic malignancy. She is also studying the genetic causes of aplastic anemia. She is co-director of the Pediatric Cancer Genetic Risk clinic and the director of the Pediatric Bone Marrow Failure clinic.
Dana Farber Cancer Institute and Boston Children's Hospital
Boston, MA
Fellowship - Pediatric Hematology-Oncology
2005
Boston Children's Hospital
Boston, MA
Residency - Pediatrics
2002
University of Wisconsin
Madison, WI
MD - Medicine
1999
University of Wisconsin
Madison, WI
PhD - Cancer Biology
1997
University of Chicago
Chicago, IL
AB - Biology
1990
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations.
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations. Pediatr Blood Cancer. 2024 Aug; 71(8):e31075.
PMID: 38764170
Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations.
Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations. Pediatr Blood Cancer. 2024 Aug; 71(8):e31070.
PMID: 38757488
Sequential tumor molecular profiling identifies likely germline variants.
Sequential tumor molecular profiling identifies likely germline variants. Genet Med. 2024 03; 26(3):101037.
PMID: 38054407
Immune gene variation associated with chromosome-scale differences among individual zebrafish genomes.
Immune gene variation associated with chromosome-scale differences among individual zebrafish genomes. Sci Rep. 2023 05 13; 13(1):7777.
PMID: 37179373
A highly diverse set of novel immunoglobulin-like transcript (NILT) genes in zebrafish indicates a wide range of functions with complex relationships to mammalian receptors.
A highly diverse set of novel immunoglobulin-like transcript (NILT) genes in zebrafish indicates a wide range of functions with complex relationships to mammalian receptors. Immunogenetics. 2023 02; 75(1):53-69.
PMID: 35869336
Hemorrhagic Shock after Neonatal Circumcision: Severe Congenital Factor XIII Deficiency.
Hemorrhagic Shock after Neonatal Circumcision: Severe Congenital Factor XIII Deficiency. Case Rep Pediatr. 2021; 2021:5550199.
PMID: 34007504
Synthetic CRISPR/Cas9 reagents facilitate genome editing and homology directed repair.
Synthetic CRISPR/Cas9 reagents facilitate genome editing and homology directed repair. Nucleic Acids Res. 2020 04 17; 48(7):e38.
PMID: 32064511
Splicing up hematopoietic development.
Splicing up hematopoietic development. Blood. 2019 02 21; 133(8):770-771.
PMID: 30792220
The side population enriches for leukemia-propagating cell activity and Wnt pathway expression in zebrafish acute lymphoblastic leukemia.
The side population enriches for leukemia-propagating cell activity and Wnt pathway expression in zebrafish acute lymphoblastic leukemia. Haematologica. 2019 07; 104(7):1388-1395.
PMID: 30630989
Genetic Models of Leukemia in Zebrafish.
Genetic Models of Leukemia in Zebrafish. Front Cell Dev Biol. 2018; 6:115.
PMID: 30294597
Regional Top Doctor, Pediatric Hematology-Oncology
Castle Connolly
2013 - now
Pritzker Scholar Award
University of Chicago
2010
Alpha Omega Alpha, Medical Honor Society
University of Wisconsin
1998
Phi Beta Kappa
University of Chicago
1990